Immatics (IMTX) FCF Margin (2019 - 2025)

Immatics' (IMTX) quarterly FCF Margin came in at 291.96% in Q4 2025, down 12036.0% year-on-year from N/an in Q4 2024, and up 65.28% quarter-over-quarter from 840.85% in Q3 2025.

Immatics (IMTX) FCF Margin (2019 - 2025) Analysis & Trends

Immatics has disclosed FCF Margin across 7 years of filings, most recently posting 291.96% for Q4 2025.

  • FCF Margin for Q4 2025 came in at 291.96%, down 12036.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 358.48% (down 22121.0% YoY), and the FY2025 annual result was 352.36%, down 26139.0% from the prior year.
  • FCF Margin came in at 291.96% for Q4 2025 at Immatics, up from 840.85% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 285.75% in Q2 2022 to a low of 840.85% in Q3 2025.
  • The 5-year median for FCF Margin is 165.34% (2024), against an average of 199.88%.
  • Across the five-year window, FCF Margin surged 64416 bps in 2022 and sank 69358 bps in 2025, its largest moves.
  • Immatics' FCF Margin stood at 149.0% in 2021, then climbed by 28 bps to 107.78% in 2022, then soared by 256 bps to 168.16% in 2023, then slumped by 202 bps to 171.61% in 2024, then sank by 70 bps to 291.96% in 2025.
  • The last three FCF Margin figures came in at 291.96% (Q4 2025), 840.85% (Q3 2025), and 794.32% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -3.98%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 43.35%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Immatics 14.67 Bn 14.67 Bn - -291.96%

Historic Data

Download Data
DateValue
Dec 31, 2025 -291.96%
Sep 30, 2025 -840.85%
Jun 30, 2025 -794.32%
Mar 31, 2025 -167.53%
Dec 31, 2024 -171.61%
Sep 30, 2024 -147.28%
Jun 30, 2024 -163.14%
Mar 31, 2024 -77.41%
Dec 31, 2023 168.16%
Sep 30, 2023 -405.40%
Jun 30, 2023 18.25%
Mar 31, 2023 -198.02%
Dec 31, 2022 -107.78%
Sep 30, 2022 -151.18%
Jun 30, 2022 285.75%
Mar 31, 2022 105.48%
Dec 31, 2021 -149.00%
Sep 30, 2021 -333.94%
Jun 30, 2021 -358.41%
Mar 31, 2021 -217.37%